vs
Side-by-side financial comparison of OLB GROUP, INC. (OLB) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
OLB GROUP, INC. is the larger business by last-quarter revenue ($1.8M vs $1.4M, roughly 1.3× PLUS THERAPEUTICS, INC.). OLB GROUP, INC. runs the higher net margin — -83.7% vs -417.9%, a 334.2% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -35.2%). Over the past eight quarters, PLUS THERAPEUTICS, INC.'s revenue compounded faster (-9.7% CAGR vs -28.7%).
OLB Group, Inc. is a global financial technology provider offering omnichannel payment processing solutions, e-commerce enablement tools, and digital banking services for small and medium-sized enterprises across North America, Europe, and key Asia-Pacific markets. Its core segments include merchant services, crypto payment integration, and cloud-based business management platforms.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
OLB vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8M | $1.4M |
| Net Profit | $-1.5M | $-5.7M |
| Gross Margin | — | — |
| Operating Margin | -83.7% | -420.0% |
| Net Margin | -83.7% | -417.9% |
| Revenue YoY | -35.2% | -3.2% |
| Net Profit YoY | 67.5% | -46.4% |
| EPS (diluted) | $-0.48 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8M | $1.4M | ||
| Q3 25 | $2.3M | $1.4M | ||
| Q2 25 | $2.3M | $1.4M | ||
| Q1 25 | $2.3M | $1.1M | ||
| Q4 24 | $2.7M | $1.4M | ||
| Q3 24 | $3.1M | $1.5M | ||
| Q2 24 | $3.5M | $1.3M | ||
| Q1 24 | $3.5M | $1.7M |
| Q4 25 | $-1.5M | $-5.7M | ||
| Q3 25 | $-1.2M | $-4.4M | ||
| Q2 25 | $-2.1M | $5.2M | ||
| Q1 25 | $-1.1M | $-17.4M | ||
| Q4 24 | $-4.6M | $-3.9M | ||
| Q3 24 | $-1.6M | $-2.9M | ||
| Q2 24 | $-2.6M | $-2.9M | ||
| Q1 24 | $-2.4M | $-3.3M |
| Q4 25 | -83.7% | -420.0% | ||
| Q3 25 | -49.1% | -320.8% | ||
| Q2 25 | -74.8% | -110.6% | ||
| Q1 25 | -36.6% | -333.9% | ||
| Q4 24 | -166.0% | -276.2% | ||
| Q3 24 | -52.9% | -260.9% | ||
| Q2 24 | -74.3% | -289.1% | ||
| Q1 24 | -82.6% | -196.7% |
| Q4 25 | -83.7% | -417.9% | ||
| Q3 25 | -50.8% | -316.6% | ||
| Q2 25 | -93.7% | 370.6% | ||
| Q1 25 | -46.9% | -1643.2% | ||
| Q4 24 | -167.1% | -276.4% | ||
| Q3 24 | -52.9% | -197.4% | ||
| Q2 24 | -75.2% | -229.9% | ||
| Q1 24 | -67.8% | -194.5% |
| Q4 25 | $-0.48 | $0.95 | ||
| Q3 25 | $-0.13 | $-0.04 | ||
| Q2 25 | $-0.66 | $-0.01 | ||
| Q1 25 | $-0.47 | $-1.19 | ||
| Q4 24 | $-3.55 | $-0.51 | ||
| Q3 24 | $-0.92 | $-0.37 | ||
| Q2 24 | $-1.49 | $-0.71 | ||
| Q1 24 | $-0.14 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.6M | $4.0M |
| Total Assets | $12.3M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $6.9M | ||
| Q1 25 | $29.3K | $9.9M | ||
| Q4 24 | $27.4K | $3.6M | ||
| Q3 24 | $41.3K | $4.8M | ||
| Q2 24 | $53.3K | $8.4M | ||
| Q1 24 | $3.3K | $3.2M |
| Q4 25 | $4.6M | $4.0M | ||
| Q3 25 | $5.3M | $5.1M | ||
| Q2 25 | $6.4M | $3.0M | ||
| Q1 25 | $2.3M | $-23.6M | ||
| Q4 24 | $3.2M | $-8.9M | ||
| Q3 24 | $6.7M | $-5.2M | ||
| Q2 24 | $8.3M | $-7.6M | ||
| Q1 24 | $11.0M | $-4.8M |
| Q4 25 | $12.3M | $16.3M | ||
| Q3 25 | $12.2M | $18.7M | ||
| Q2 25 | $12.4M | $10.3M | ||
| Q1 25 | $12.5M | $12.1M | ||
| Q4 24 | $12.7M | $6.6M | ||
| Q3 24 | $15.9M | $7.0M | ||
| Q2 24 | $16.6M | $11.2M | ||
| Q1 24 | $18.3M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.3M | $-6.3M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -459.9% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.3M | $-6.3M | ||
| Q3 25 | $-115.5K | $-2.5M | ||
| Q2 25 | $-1.0M | $-5.8M | ||
| Q1 25 | $-155.8K | $-6.2M | ||
| Q4 24 | $-2.6M | $-1.2M | ||
| Q3 24 | $-376.7K | $-3.7M | ||
| Q2 24 | $-785.5K | $-1.1M | ||
| Q1 24 | $-424.7K | $-4.5M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-5.8M | ||
| Q1 25 | — | $-6.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $-4.6M |
| Q4 25 | — | -459.9% | ||
| Q3 25 | — | -184.3% | ||
| Q2 25 | — | -417.6% | ||
| Q1 25 | — | -583.1% | ||
| Q4 24 | — | -86.5% | ||
| Q3 24 | — | -253.7% | ||
| Q2 24 | — | -96.2% | ||
| Q1 24 | — | -271.5% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 6.3% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLB
| Transaction And Processing Fees | $1.7M | 94% |
| Other | $99.2K | 6% |
PSTV
Segment breakdown not available.
